In addition, elevated CHAF1B expression has been associated with advanced tumor grade and staging in melanoma, high-grade glioma, salivary gland tumors, prostate, endometrial, renal, and cervical cancers (40–44). This evidence concerns the gene CHAF1B and central nervous system cancer.